Loading...
COVID 19 Vaccines: Should we fear ADE?
Might COVID 19 vaccines sensitize humans to antibody dependent enhanced (ADE) breakthrough infections? This outcome is unlikely because coronavirus diseases in humans lack the clinical, epidemiological, biological or pathological attributes of ADE disease exemplified by the dengue viruses (DENV). In...
Saved in:
| Published in: | J Infect Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7454712/ https://ncbi.nlm.nih.gov/pubmed/32785649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa518 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|